Bryon D Johnson

T. Braun, P. Hari, M. Pasquini, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Diacylglycerol Kinase ζ (DGKζ) and Casitas b-Lineage Proto-Oncogene b–Deficient Mice Have Similar Functional Outcomes in T Cells but DGKζ-Deficient Mice Have Increased T Cell Activation and Tumor Clearance

Bryon D Johnson, S. Malarkannan, M. Riese, 2018, ImmunoHorizons.

Potentiation of Kras peptide cancer vaccine by avasimibe, a cholesterol modulator

R. Shoemaker, M. You, Bryon D Johnson, 2019, EBioMedicine.

Intrathecal chemotherapy for management of steroid-refractory CAR T-cell-associated neurotoxicity syndrome.

P. Hari, Bryon D Johnson, N. Shah, 2020, Blood advances.

The T cell activation marker CD150 can be used to identify alloantigen-activated CD4(+)25+ regulatory T cells.

Bryon D Johnson, M. Konkol, R. Truitt, 2004, Cellular immunology.

CD25+ immunoregulatory T-cells of donor origin suppress alloreactivity after BMT.

Bryon D Johnson, M. Konkol, R. Truitt, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Following Donor Leukocyte Infusion Therapy Suppression of Graft-Versus-Host Disease Role of Immunoregulatory Donor T Cells in

Bryon D Johnson, R. Truitt, J. LaBelle, 1999 .

Induction of immunity to neuroblastoma early after syngeneic hematopoietic stem cell transplantation using a novel mouse tumor vaccine.

Bryon D Johnson, R. Orentas, Weiqing Jing, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Suppression of anti-cancer immunity by regulatory T cells: back to the future.

Bryon D Johnson, R. Orentas, M. Kohler, 2006, Seminars in cancer biology.

Tracking ex vivo-expanded CD4+CD25+ and CD8+CD25+ regulatory T cells after infusion to prevent donor lymphocyte infusion-induced lethal acute graft-versus-host disease.

Bryon D Johnson, R. Truitt, G. Xia, 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras.

Bryon D Johnson, R. Truitt, G. Xia, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Dual expression of CD80 and CD86 produces a tumor vaccine superior to single expression of either molecule.

Bryon D Johnson, R. Orentas, Xiaocai Yan, 2003, Cellular immunology.

Adoptive cell therapy using PD-1+ myeloma-reactive T cells eliminates established myeloma in mice

Bryon D Johnson, M. Riese, J. Gershan, 2017, Journal of Immunotherapy for Cancer.

Immune response modulation by curcumin in a latex allergy model

V. Kurup, Bryon D Johnson, J. Fink, 2007, Clinical and molecular allergy : CMA.

Cellular immune response to an engineered cell-based tumor vaccine at the vaccination site.

Qiang Zhou, Bryon D Johnson, R. Orentas, 2007, Cellular immunology.

Immune modulating effects of cyclophosphamide and treatment with tumor lysate/CpG synergize to eliminate murine neuroblastoma

Bryon D Johnson, J. Gershan, James J. Weber, 2015, Journal of Immunotherapy for Cancer.

Therapeutic expression of the platelet-specific integrin, alphaIIbbeta3, in a murine model for Glanzmann thrombasthenia.

R. Hynes, Bryon D Johnson, Juan Fang, 2005, Blood.

HMGB1 release by urothelial carcinoma cells is required for the in vivo antitumor response to Bacillus Calmette-Guérin.

W. See, Bryon D Johnson, Guang-jian Zhang, 2013, The Journal of urology.

Tocilizumab, tacrolimus and methotrexate for the prevention of acute graft-versus-host disease: low incidence of lower gastrointestinal tract disease

P. Hari, M. Pasquini, M. Horowitz, 2018, Haematologica.

Associations between socioeconomic status and bispecific LV20.19 CAR T cell therapy outcomes.

Bryon D Johnson, A. Szabo, C. Hillard, 2021, Haematologica.

the Inhibition of Antitumor T Cell Reactivity to Inhibitory Factor by Neuroblastoma Leads Expression of Macrophage Migration

Qiang Zhou, Bryon D Johnson, R. Orentas, 2013 .

Expression of Macrophage Migration Inhibitory Factor by Neuroblastoma Leads to the Inhibition of Antitumor T Cell Reactivity In Vivo1

Qiang Zhou, Bryon D Johnson, R. Orentas, 2008, The Journal of Immunology.

Long‐term outcomes and predictors of early response, late relapse, and survival for patients treated with bispecific LV20.19 CAR T‐cells

P. Hari, Bryon D Johnson, A. Szabo, 2022, American journal of hematology.

Neuroblastoma Vaccine Expressing CD 137 L Effector T Cell Population by a Cell-Based Induction of a VLA-2 ( CD 49 b )-Expressing

Bryon D Johnson, R. Orentas, Xiaocai Yan, 2008 .

Treatment-Emergent Tumor Lysis Syndrome With PI3Kδ-γ Inhibition After CAR T-Cell Therapy for Chronic Lymphocytic Leukemia.

P. Hari, Bryon D Johnson, N. Shah, 2020, JCO oncology practice.

An updated single center experience with plerixafor and granulocyte colony‐stimulating factor for stem cell mobilization in light chain amyloidosis

P. Hari, Bryon D Johnson, A. Szabo, 2019, Journal of clinical apheresis.

Purified and Recombinant Latex Proteins Stimulate Peripheral Blood Lymphocytes of Latex Allergic Patients

D. Beezhold, V. Kurup, Bryon D Johnson, 1999, International Archives of Allergy and Immunology.

Donor chimerism and immune reconstitution following haploidentical transplantation in sickle cell disease

Bryon D Johnson, J. Verbsky, M. Cairo, 2022, Frontiers in Immunology.

Utilization and cost implications of hematopoietic progenitor cells stored for a future salvage autologous transplantation or stem cell boost in myeloma patients.

P. Hari, M. Pasquini, Bryon D Johnson, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.